E-Presentation

Refresh Page View All

Prostate-specific membrane antigen (PSMA) in circulating tumor cells (CTCs) is a new poor prognostic marker for castration-resistant prostate cancer (CRPC).

Paper No: 362 | Oncology - Prostate Cancer
Masayoshi Nagata

3-Minues Oral Presentation 7 | Oncology (Prostate) 3

08 Aug 2019 | 13:30:00-14:30:00

Back to Top